Legend Biotech names Alan Bash interim CEO
Ying Huang has stepped down as Legend Biotech CEO and board member. Alan Bash will lead the cell therapy company on an interim basis.
Ying Huang has stepped down as Legend Biotech CEO and board member. Alan Bash will lead the cell therapy company on an interim basis.
The German Heart Foundation has launched a nationwide EMAH campaign to encourage adults with congenital heart disease to attend follow-up care.
Carsten Linnemann is set to take over Germany’s health ministry, while Nina Warken is expected to move to the Chancellery.
LINDA AG is introducing Ibuprofen 400 mg as the first OTC medicine under its own pharmacy brand across LINDA Premium pharmacies.
Novo Nordisk has sued Eli Lilly in the US over GLP-1 campaigns for Zepbound and Mounjaro, alleging misleading comparative ads.
Mediengruppe Deutscher Apotheker Verlag is reorganizing its management board in response to changes in its market environment.
Convatec is preparing a CFO change. Fiona Ryder will remain until a successor is appointed, while Tobias Hestler joins the board.
Sanofi will reshape its Executive Committee on September 1, 2026, with changes across R&D, business units, finance and regional roles.
Tarsus Pharmaceuticals says CCO Aziz Mottiwala will depart, with Neera Clase taking over the commercial role on an interim basis.
Thieme is launching Thieme Praxis, a digital platform and app for medical information, CME content and tools in physicians’ daily work.